Evidence map›Paper›PMID 38011090›Full record

ArticlePloS one2023

Nrf1 is not a direct target gene of SREBP1, albeit both are integrated into the rapamycin-responsive regulatory network in human hepatoma cells.

Keli Liu, Shaofan Hu, Lu Qiu, Meng Wang, Zhengwen Zhang, Guiyin Sun, Yiguo Zhang

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Keli LiuBioengineering College, Chongqing University, Shapingba District, Chongqing, China.
Shaofan HuBioengineering College, Chongqing University, Shapingba District, Chongqing, China.
Lu QiuBioengineering College, Chongqing University, Shapingba District, Chongqing, China.
Meng WangBioengineering College, Chongqing University, Shapingba District, Chongqing, China.
Zhengwen ZhangLaboratory of Neuroscience, Institute of Cognitive Neuroscience and School of Pharmacy, University College London, London, England, United Kingdom.
Guiyin SunChongqing University Jiangjin Hospital, School of Medicine, Chongqing University, Jiangjin District, Chongqing, China.
Yiguo ZhangChongqing University Jiangjin Hospital, School of Medicine, Chongqing University, Jiangjin District, Chongqing, China.ORCID 0000-0003-3910-2779
Chongqing University · CNUniversity College London · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The essential role of protein degradation by ubiquitin-proteasome system is exerted primarily for maintaining cellular protein homeostasis. The transcriptional activation of proteasomal genes by mTORC1 signaling depends on Nrf1, but whether this process is directly via SREBP1 remains elusive. In this study, our experiment evidence revealed that Nrf1 is not a direct target of SREBP1, although both are involved in the rapamycin-responsive regulatory networks. Closely scrutinizing two distinct transcriptomic datasets unraveled no significant changes in transcriptional expression of Nrf1 and almost all proteasomal subunits in either siSREBP2-silencing cells or SREBP1-∕-MEFs, when compared to equivalent controls. However, distinct upstream signaling to Nrf1 dislocation by p97 and its processing by DDI1/2, along with downstream proteasomal expression, may be monitored by mTOR signaling, to various certain extents, depending on distinct experimental settings in different types of cells. Our further evidence has been obtained from DDI1-∕-(DDI2insC) cells, demonstrating that putative effects of mTOR on the rapamycin-responsive signaling to Nrf1 and proteasomes may also be executed partially through a DDI1/2-independent mechanism, albeit the detailed regulatory events remain to be determined.

Indexed as

Carcinoma, HepatocellularLiver NeoplasmsNF-E2-Related Factor 1HumansProteasome Endopeptidase ComplexProteolysisSterol Regulatory Element Binding Protein 1TOR Serine-Threonine KinasesNFE2L1 protein, humanNF-E2-Related Factor 1Proteasome Endopeptidase ComplexSREBF1 protein, humanSterol Regulatory Element Binding Protein 1TOR Serine-Threonine Kinases

Identifiers

PMID38011090
PMCPMC10681226
OpenAlexW4389044829

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.